In this peer-reviewed article (published in the Belgian journal Facts, Views and Vision in Obstetrics and Gynaecology), Dr Prior outlines the scientific evidence behind the use of oral micronized progesterone in the treatment of symptomatic perimenopause. Health care providers will find current woman-centred and physiology-based information to help them address the needs of their symptomatic perimenopausal patients.